Boston Trust Walden Corp Novartis Ag Transaction History
Boston Trust Walden Corp
- $14 Billion
- Q4 2024
A detailed history of Boston Trust Walden Corp transactions in Novartis Ag stock. As of the latest transaction made, Boston Trust Walden Corp holds 2,205 shares of NVS stock, worth $246,695. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,205
Previous 2,163
1.94%
Holding current value
$246,695
Previous $248,000
13.71%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding NVS
# of Institutions
1,477Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.37 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.23 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$916 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$769 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$624 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $241B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...